Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

IMPACT OF THERAPY INTENSIFICATION BY AN INTEGRASE INHIBITOR +/- CCR5 INHIBITOR ON THE LYMPHOID RESERVOIR FOR HIV-1 IN CHRONICALLY INFECTED PATIENTS

NCT00935480 is registered in ClinicalTrials.gov with Centre Hospitalier Intercommunal de Toulon La Seyne sur Mer as lead sponsor.

NCT NCT00935480
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00935480 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
IMPACT OF THERAPY INTENSIFICATION BY AN INTEGRASE INHIBITOR +/- CCR5 INHIBITOR ON THE LYMPHOID RESERVOIR FOR HIV-1 IN CHRONICALLY INFECTED PATIENTS
Lead sponsor
Centre Hospitalier Intercommunal de Toulon La Seyne sur Mer
Phase
Phase 3
Overall status
Completed
Start date
October 31, 2010
Completion date
August 8, 2014
Enrollment
17 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

hiv infections